PMC7930232_01
Platelets and creatinine levels during the first 33 days of patient's life:Refractory thrombocytopenia and severe renal failure developed on day 2 of life. Improvements have been observed after administration of Eculizumab on day 9 of life. FFP, Fresh frozen plasma.
fped-08-579607-g0001.jpg
PMC7930232_01_fped-08-579607-g0001.jpg
F1
Kidney function started to improve 3 days after the administration of Eculizumab, while coagulation and platelet count improved between days 5 and 14 (Figure 1).